Digital Health innovation has the potential to transform patient care and lower healthcare costs. But what’s needed to realize these promising solutions? Panelists will explain how pharma, academia, patient advocacy and the startup ecosystem can engage together to develop new technologies that provide critical information to physicians and patients suffering from illnesses such as Congestive Heart Failure (CHF) and Chronic Kidney Disease (CKD). In addition to high rates of mortality, these diseases are some of the most expensive to treat and re-hospitalizations impact patients’ quality of life as well as serve as a major driver of cost. The panelists will showcase a new model to effectively develop digital health solutions that go beyond traditional therapeutics and provide a path toward treating the whole patient.